Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Doxycycline to Prevent Bacteremia Following Dental Extractions
NCT06422221Phase 4Not yet recruiting
- Sponsor
- Universidad de Santiago de Compostela
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of doxycycline in Bacteremia and infective endocarditis (IE) (3 arms), sponsored by Universidad de Santiago de Compostela. Primary endpoint: Prevalence of bacteremia. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
Bacteremiainfective endocarditis (IE)
Beyond the preview
Go deeper on NCT06422221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06422221.